Kimberly Manhard - 28 Aug 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role
Director
Signature
/s/ Kelly D. Deck, as attorney-in-fact for Kimberly Manhard
Issuer symbol
INBX
Transactions as of
28 Aug 2024
Net transactions value
+$139,800
Form type
4
Filing time
30 Aug 2024, 16:16:36 UTC
Previous filing
30 May 2024
Next filing
29 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBX Common Stock Purchase $139,800 +10,000 $13.98 10,000 28 Aug 2024 Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple transactions at prices ranging from $13.925 to $14.04, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012.